1987 Saab 900 Turbo Hatchback 2-door 2.0l on 2040-cars

Auto blog

Vampire Weekend singer responds to burning Saab controversy [w/video]

Last week, we tipped you off about Vampire Weekend and their new music video for the song Diane Young, a short film that consists entirely of setting fire to two perfectly nice-looking Saab 900 automobiles. The indie rock band's video - viewable by scrolling down - predictably triggered the internet ire of classic car enthusiasts - Saabophiles in particular - and word of the unrest eventually got back to the band itself.
According to music site Spinner (nb: owned by Autoblog parent AOL), the group was "stunned" at the backlash - enough that lead singer Ezra Koenig felt compelled to respond himself. According to Koenig, the band was under the impression that their record company was "looking to purchase the cheapest, oldest cars possible; they weren't trying to buy a beautiful perfect condition car." By way of apology, Koenig even goes so far as to note that bandmate Rostam Batmanglij is a keen fan of Saab.
Other reports have claimed that the cars may have been purchased under false pretenses, sold by owners who "wanted to see them go to a nice new home," but Koenig takes issue with that characterization, countering that he understood that the cars had substantial electrical problems.

Future Classic: 1999-2002 Saab 9-3 Viggen

Given the company’s now-defunct status, you could argue that all Saabs are future classics. Even the final round of cars from the era of General Motors ownership deserve their place in history. Seriously, how hot was the last 9-5? Handsome design and quirky features were hallmarks of the Saab brand, and its cars felt every bit as premium as its primary European competitors. But while other luxury carmakers put great effort into full lineups of performance cars, Sweden only produced the odd sporty Saab every once in a while. One of our favorites was the 9-3 Viggen from the turn of the century, and itÂ’s a car that still makes us swoon today. Why is the Saab 9-3 Viggen a future classic? Saab's whole "born from jets" tagline never really made much sense, but at least the 9-3 Viggen's name was a nod to the company's aerospace roots. The Swedish word "Viggen" translates to "thunderbolt" in English, and this name was used on the Saab 37 Viggen aircraft that entered service in the early 1970s. MotorWeek | Retro Review: '99 Saab Viggen The 9-3 Viggen used a turbocharged 2.3-liter inline-four engine, most notably remembered for its eyebrow-raising 20 psi of boost pressure. Rated at 225 horsepower – which was later bumped up to 230 hp – and 252 pound-feet of torque, this engine was paired exclusively with a five-speed manual transmission and front-wheel drive. Stiffer suspension components, firmer dampers, stronger driveshafts, a heavy-duty clutch and a revised exhaust were also part of the package. The Viggen was relatively quick, with Saab quoting a 0-to-60-mph time of around 6.5 seconds. However, the 9-3 Viggen is largely remembered for things like its ridiculous turbo lag and torque steer – characteristics that kind of made this car hilarious to drive, even if they took away from overall sharpness and composure. What is the ideal example of the Saab 9-3 Viggen? Saab offered the 9-3 Viggen as a three-door hatchback, five-door hatchback and two-door convertible. And while this car is most commonly remembered in its launch shade, Lightning Blue, Saab offered the Viggen in black, gray, red, silver and yellow. You could even spec the interior with blue, orange or tan leather accents. Arguably the most iconic 9-3 Viggen spec is a Lightning Blue three-door hatch, but the other colors are far more rare. WeÂ’ve got a major soft spot for a Monte Carlo Yellow five-door, but really, you canÂ’t go wrong.

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.